NKGen Biotech, Inc. Common Stock (NKGEN) is a biotechnology company specializing in the development and research of therapeutic products utilizing natural killer (NK) cells. Their main focus is on harnessing the body's immune system to fight against cancer and other diseases.
Feed
There are no posts to show right now.
Używamy ciasteczek, aby ulepszyć Twoje doświadczenie na naszej stronie.
